KB Partners is a Chicago-based venture capital firm specializing in early-stage investments at the intersection of sports and technology. The firm typically participates in seed rounds but also engages in Series A and B funding. KB Partners seeks passionate innovators and leverages its deep industry networks to support the growth of its portfolio companies.
Notable portfolio companies include Alembic, Omorpho, Phenix, and Verax Biomedical. The firm prides itself on an "Entrepreneurs for Entrepreneurs" philosophy, emphasizing hands-on experience and a proven track record in guiding startups. KB Partners offers unique value-add services, including strategic guidance and leveraging its extensive networks within the sports and technology sectors to drive exponential growth for its portfolio companies.
KB Partners - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Total Investments38
Current Portfolio Count24
Total Portfolio Exits0
Top Investment Stages
Seed23 (63.9%)
Series Unknown5 (13.9%)
Series A4 (11.1%)
Series B3 (8.3%)
Pre-Seed1 (2.8%)
Stage Mix
Seed 64%Series Unknown 14%Series A 11%Series B 8%Pre-Seed 3%
Concentration shown as share of disclosed investments by stage.
KB Partners - Classification
- NAICS
- 520000Finance and Insurance
- 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
- 523900Other Financial Investment Activities
- 523990All Other Financial Investment Activities
- 523999Miscellaneous Financial Investment Activities
- SIC
- 6700Holding And Other Investment Offices
- 6790Miscellaneous Investing
- 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
- NAICS
- 525000Funds, Trusts, and Other Financial Vehicles
- 523910Miscellaneous Intermediation
- 523940Portfolio Management and Investment Advice
- SIC
- 6000Depository Institutions
- 6720Investment Offices
- 6722Management Investment Offices, Open-end